{
    "clinical_study": {
        "@rank": "156232", 
        "acronym": "TORSIV", 
        "arm_group": [
            {
                "arm_group_label": "I.V. sedation", 
                "arm_group_type": "Experimental", 
                "description": "Patients who will undergo bronchoscopy will be followed during one day. They will be randomized in the I.V. sedation"
            }, 
            {
                "arm_group_label": "sublingual sedation", 
                "arm_group_type": "Active Comparator", 
                "description": "Patients who will undergo bronchoscopy will be followed during one day. They will be randomized in the sublingual sedation group"
            }
        ], 
        "brief_summary": {
            "textblock": "Bronchoscopy is a technique which currently allows the investigation of many respiratory\n      diseases (infections, neoplasia, inflammation\u2026) as well as endobronchial therapeutic\n      procedures.\n\n      Good flexible bronchoscopy diagnostic practices suggest the use of anxiolytic premedication\n      before endoscopy, but practices concerning the use of sedation further to the completion of\n      the endoscopy are very heterogeneous.\n\n      We thus propose to compare, during a randomize, controlled trial, respiratory tolerance to\n      I.V. versus sublingual sedation in two groups of patients indergoing bronchoscopy"
        }, 
        "brief_title": "Comparison of Respiratory Tolerance to I.V. Versus Sublingual Sedation During Bronchoscopy. (TORSIV)", 
        "completion_date": {
            "#text": "November 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Sedation During Bronchoscopy", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Men or women aged between 18 and 80, who will undergo bronchoscopy\n\n          -  FEV1\u2265 50% of theorical value\n\n          -  Ambient air saturation at rest \u2265 94%\n\n          -  No allergy to midazolam, to hydroxyzine, Lidocaine (used for local anesthesia) or one\n             of their compound\n\n          -  fasting for at least 6 hours\n\n          -  No indication against bronchoscopy, nor to premedication\n\n          -  Informed consent signed\n\n        Exclusion Criteria:\n\n          -  Pregnant or lactating, women\n\n          -  PAH patients\n\n          -  patients undergoing bronchoscopy with bronchoalveolar lavage and / or trans-bronchial\n             biopsy\n\n          -  Patients with oral anticoagulants"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "84", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 1, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01698892", 
            "org_study_id": "12_0208"
        }, 
        "intervention": [
            {
                "arm_group_label": "I.V. sedation", 
                "description": "Patients who will undergo bronchoscopy will be followed during one day. They will be randomized in the I.V. sedation group", 
                "intervention_name": "I.V Sedation", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "sublingual sedation", 
                "description": "Patients who will undergo bronchoscopy will be followed during one day. They will be randomized in the sublingual sedation group", 
                "intervention_name": "sublingual sedation", 
                "intervention_type": "Drug"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": "I.V. sedation, midazolam, bronchoscopy", 
        "lastchanged_date": "February 19, 2014", 
        "location": {
            "contact": {
                "email": "arnaud.cavailles@chu-nantes.fr", 
                "last_name": "ARNAUD CAVAILLES, PH", 
                "phone": "02.40.16.52.38"
            }, 
            "facility": {
                "address": {
                    "city": "Nantes", 
                    "country": "France", 
                    "zip": "44000"
                }, 
                "name": "Cavailles"
            }, 
            "investigator": {
                "last_name": "ARNAUD CAVAILLES, PH", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "2", 
        "official_title": "Comparison of Respiratory Tolerance to I.V. Versus Sublingual Sedation During Bronchoscopy.", 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "France : ANSM", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "November 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Intensity of dyspnea assessed by the patient 1h after bronchoscopy in both groups measured by VAS (visual analogue scale) score (in millimeters on a 0 to 100 scale).", 
            "measure": "Intensity of dyspnea", 
            "safety_issue": "No", 
            "time_frame": "1 day"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01698892"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "VAS Individual scores performed 1 hour after bronchoscopy (cough, nausea, pain, anxiety, overall tolerance)", 
                "measure": "VAS Individual scores", 
                "safety_issue": "No", 
                "time_frame": "1 day"
            }, 
            {
                "description": "Blood pressure (mean blood pressure measurements made before, during and after the exam)", 
                "measure": "Blood pressure", 
                "safety_issue": "No", 
                "time_frame": "1 day"
            }, 
            {
                "description": "Desaturation frequency during bronchoscopy, defined by the lowering of transcutaneous oxygen saturation below 90%", 
                "measure": "Desaturation frequency", 
                "safety_issue": "No", 
                "time_frame": "1 day"
            }, 
            {
                "description": "Initial and maximum heart rate during bronchoscopy (continuous monitoring)", 
                "measure": "heart rate", 
                "safety_issue": "No", 
                "time_frame": "1 day"
            }, 
            {
                "description": "OAAS Score after bronchoscopy", 
                "measure": "OAAS Score", 
                "safety_issue": "No", 
                "time_frame": "1 day"
            }, 
            {
                "description": "Bronchoscopy duration (time difference between the input and output of the examination room, and between the start and end of bronchoscopy)", 
                "measure": "Bronchoscopy duration", 
                "safety_issue": "No", 
                "time_frame": "1 day"
            }, 
            {
                "description": "Comparison of midazolam total dose administered in each group", 
                "measure": "Comparison of midazolam total dose", 
                "safety_issue": "No", 
                "time_frame": "1 day"
            }
        ], 
        "source": "Nantes University Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Nantes University Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2012", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}